Press Releases
Read the latest company news, product launches, media coverage, R&D breakthroughs, and industry developments.
2026.08.10
GBC July Revenue Reaches NT$24.63 Million, Up 57.82% YoY
Find Out More
2026.07.14
GBC Showcases CLIA and AIO Platforms at WHX Bangkok, Expanding Opportunities in Southeast Asia
Find Out More
2026.06.17
GBC 2025 EPS Reaches Record High of NT$7.46 as Trading Resumes, Advancing Transformation and Growth
Find Out More
2025.05.21
GBC AI Biotech Building Officially Commissioned. Advancing AI Precision Medicine and Expanding Holistic Health Strategy.
Find Out More
2025.01.16
GBC’s CellBio™ FX10 Receives 2024 SNQ Symbol of National Quality Certification
Find Out More
2024.12.04
GBC Chemiluminescence Analyzer Secures TFDA Certification, Boosting Business Momentum
Find Out More
2024.11.28
GBC CellBio™ Circulating Tumor Cell Detection System Wins the 2024 Taiwan Excellence Award
Find Out More
2024.04.02
GBC Signs Exclusive Distribution Agreement with Brazilian Partner, Gradual Deliveries to Commence from April.
Find Out More
2023.11.21
GBC CellBio™ Technology Platform received the Bronze Award at the National Pharmaceutical Technology & Research Development Awards.
Find Out More
2023.07.24
General Biologicals Corporation Debuts Award-Winning Brand at Scientific Clinical Lab Expo
Find Out More
2022.08.19
GBC in Taiwan received the coveted HR Asia Best Companies to Work for in Asia 2022 Award
Find Out More
2022.08.11
In the first half of the year, GBC EPS reached NTD 0.23, the third highest performance in the same period of the previous year
Find Out More
2022.07.28
GBC expanding CellBio™ Circulating Tumor Cell (CTC)
Find Out More
2020.07.06
General Biologicals Corporation (GBC) Develops COVID-19 Testing Solutions for Antigen and Antibody Detection
Find Out More
Events
We try to participate as many events or shows as much as possible. Try to capture us demoing the newest technologies at the events below.
JACLaS EXPO 2026
When
2026/10/08 – 10/10
Where
Kobe International Exhibition Hall 3
Booth
66
GBC is pleased to announce our participation in JACLaS EXPO 2026. We warmly invite you to visit our booth and discover the latest innovations in Circulating Tumor Cell (CTC) and liquid biopsy technologies. Our team will be available to discuss our latest developments, product applications, and opportunities for future collaboration. We look forward to welcoming you to our booth and meeting you in Kobe! ｜Exhibition Information ˙Exhibition: JACLaS EXPO 2026˙Date: October 8 (Thu) – 10 (Sat), 2026˙Venue: Kobe International Exhibition Hall, Kobe, Japan˙Hall: Hall 3˙Booth: 66
World Health Expo Bangkok
When
2026/07/08 – 07/10
Where
Queen Sirikit National Convention Center (QSNCC)
Booth
M23
Dear Partner, We warmly invite you to join us at 2026 WHX Labs Bangkok, taking place at the Queen Sirikit National Convention Center (QSNCC) in Bangkok, Thailand. This is a great opportunity to discover GBC’s newest innovations and comprehensive solutions in the field of In Vitro Diagnostics (IVD). What We’re Showcasing CellBio CTC Circulating Tumor Cell Detection PlatformAn advanced, non-invasive technology designed to isolate circulating tumor cells (CTCs) from blood samples. It enables multi-dimensional analysis across DNA, RNA, and proteins, supporting applications such as early cancer screening, treatment monitoring, and precision medicine development. CLIA Chemiluminescence Immunoassay SystemEngineered to meet the needs of laboratories and healthcare institutions of all sizes, this system delivers both high sensitivity and efficiency. It is well-suited for a broad spectrum of clinical diagnostics, including oncology, endocrinology, and infectious disease testing. AIO Fully Automated Molecular Diagnostics System (M160)A fully integrated platform that streamlines nucleic acid extraction, amplification, and detection. Its “sample-in, result-out” design simplifies workflows, enhances productivity, and reduces the risk of manual errors. What You Can Expect On-Site Interactive live demonstrations of our latest technologies One-on-one technical consultations and tailored solution discussions Opportunities to connect and explore potential collaborations We would be honored to welcome you to the GBC booth and exchange insights on the future of precision medicine and smart diagnostics. Should you wish to arrange a meeting or guided tour in advance, please don’t hesitate to reach out. We look forward to seeing you in Bangkok!
WHX Labs World Health Expo
When
2026/02/10 – 02/13
Where
Dubai World Trade Centre
Booth
SA.D50
GBC | Sincerely Invites You to Visit Us At 2026 WHX Labs Dubai Dear Partner, We are delighted to invite you to visit us at 2026 WHX Labs Dubai and experience firsthand GBC’s latest technologies and integrated solutions in the field of In Vitro Diagnostics (IVD). Exhibition Dates: February 10–13, 2026Venue: Dubai World Trade CentreBooth No. SA.D50 Key Exhibits & Highlights CellBio™ CTC Circulating Tumor Cell Detection PlatformA non-invasive solution for isolating circulating tumor cells (CTCs) from blood. Supports multi-level detection of DNA, RNA, and proteins, enabling applications in early cancer detection, therapy response monitoring, and precision medicine research. CLIA Chemiluminescence Immunoassay SystemDesigned for small, medium, and large laboratories and hospitals. Offering high sensitivity and high throughput, it supports clinical testing needs such as tumor markers, endocrinology, and infectious diseases. AIO M160 Fully Automated Molecular Diagnostic SystemIntegrates nucleic acid extraction, amplification, and detection into a single platform. Provides a true “sample-in, result-out” automated workflow, significantly improving testing efficiency while reducing human error. On-Site Experience Highlights • Live product demonstrations • Technical consultation and solution discussions • Business meetings and partnership opportunities We sincerely invite you to visit the GBC booth and explore with us the future of precision medicine and intelligent diagnostics. Feel free to contact us to schedule a meeting or arrange a guided booth tour.
2025 Healthcare Expo Taiwan
When
2025/12/04 – 12/07
Where
Hall 1, Taipei Nangang Exhibition Center (TaiNEX 1)
Booth
M1014
Dear Valued Guest, GBC Biotech sincerely invites you to attend the 2025 Taiwan Healthcare+ Expo, where we will explore the latest trends and innovations in clinical diagnostics and smart laboratory solutions together. Exhibition Date: December 4 (Thu) – December 7 (Sun), 2025Venue: Taipei Nangang Exhibition Center, Hall 1Booth Number: M1014 At this year’s exhibition, GBC Biotech will showcase a variety of our latest instruments and integrated solutions, including: GBC AIO M160 Fully Automated Genetic & Nucleic Acid Testing System — An all-in-one platform integrating extraction and amplification to streamline and accelerate nucleic acid testing workflows. GBC CL i120 Chemiluminescence Analyzer — A high-efficiency chemiluminescent immunoassay platform. GBC Rito ELISA Plate Analyzer — A fully automated ELISA system designed to enhance testing efficiency and accuracy. GBC Wato Microplate Washer — A high-performance, reliable microplate washing solution. GBC CellBio™ a2000 Fully Automated Liquid Biopsy Platform — Designed for clinical research and precision oncology applications. We sincerely invite you to visit our booth and share your valuable insights as we witness the innovations and breakthroughs in smart diagnostic technologies together. We look forward to seeing you!
WHX Labs Cape Town
When
2025/09/02 – 09/4
Where
Cape Town International Convention Centre
Booth
H1.D17
GBC at WHX Labs Cape Town 2025: Accelerating Liquid Biopsy and Precision Diagnostics in Africa Event Overview WHX Labs Cape Town 2025, held from 2–4 September 2025 at CTICC, is Africa’s leading medical laboratory and diagnostics event under the World Health Expo series. It attracted 3,000+ attendees, 350+ exhibitors, and 200+ speakers, covering oncology, infectious diseases, AI-driven diagnostics, and integrated laboratory automation. GBC's Showcase Highlights At Booth H1.D17, GBC demonstrated a complete portfolio of integrated diagnostic solutions: CellBio™ Liquid Biopsy Systems — automated detection and enrichment of CTCs and CTMs for early cancer screening and precision oncology. ELISA Reagents — robust assays for infectious disease screening and chronic condition monitoring. CLIA CL i120 System and Reagents — high-sensitivity solutions for protein, antibody, and hormone testing. GBC AIO M160 System with Real-Time PCR Kits — all-in-one extraction-to-amplification solutions for infectious diseases and genetic markers. Self-Collection Device for HPV — enabling patient-friendly, high-compliance cervical cancer screening workflows. CDMO Services — from biomaterials to finished kits, supporting regional assay co-development. Key Learnings & Market Insights: Rising demand for CTC-based oncology workflows — especially from regional cancer centers seeking less-invasive diagnostics. Growing HPV screening awareness — NGOs and public health networks expressed strong interest in self-collection HPV testing for high-risk groups. Integrated reagents & systems appeal — the ability to deliver reagents, analyzers, and CDMO services in one ecosystem differentiated GBC. Need for regulatory-ready partnerships — African distributors requested support for CE-IVD dossiers and WHO PQ processes to accelerate adoption.
2025 BIO Asia-Taiwan
When
2025/07/24 – 07/27
Where
Taipei Nangang Exhibition Center, Hall 1, 4F
Booth
N604
This year's BIO Asia-Taiwan 2025 was held at the Taipei Nangang Exhibition Center, Hall 1, attracting biotechnology professionals, industry leaders, researchers, and investors from around the world. Together, they are exploring collaborative opportunities and gaining deeper insights into Taiwan’s innovation and progress in the biotech sector. GBC is showcasing its the CellBio™ circulating tumor cell detection product, a2000 CTC system, highlighting cutting-edge technologies in early cancer detection and monitoring. Visitors can also learn more about GBC’s high-sensitivity and high-precision diagnostic technology, including CLIA (chemiluminescent immunoassay) instruments and reagents, which are applicable to a wide range of clinical testing needs. The fully automated genetic nucleic acid detection and analysis system AIO M160 integrates DNA/RNA extraction, amplification, and data analysis, offering clinical laboratories enhanced efficiency and consistent diagnostic performance. Please stay tuned for GBC’s future developments and upcoming exhibitions worldwide. We warmly welcome all guests and partners to visit us and explore more cutting-edge technologies, products, and integrated solutions.
WHX Labs Kuala Lumpur
When
2025/07/16 – 07/18
Where
MITEC
Booth
M18
GBC at WHX Labs Kuala Lumpur 2025: Integrating Precision Diagnostics Across ASEAN Event Overview WHX Labs Kuala Lumpur 2025, hosted at MITEC from 16–18 July 2025, is Southeast Asia's flagship laboratory expo under the World Health Expo network. The event attracted 3,500+ visitors and 300+ exhibitors, with 60+ scientific talks covering digital pathology, molecular testing, HPV screening, and infectious disease control. GBC's Showcase Highlights CellBio™ Liquid Biopsy Systems — enabling oncology labs to adopt non-invasive CTC monitoring for cancer management. ELISA & CLIA Reagents — comprehensive panels covering infectious disease markers, tumor markers, and hormonal diagnostics. AIO M160 Real-Time PCR Kits — optimized for high-throughput multiplex panels in ASEAN's rapidly scaling lab environments. Self-Collection Device for HPV — addressing regional public health initiatives on cervical cancer prevention. CDMO Services — offering assay customization for ASEAN's regulatory and market needs. Key Learnings & Market Insights: PCR adoption accelerating in ASEAN — especially multiplex panels combining respiratory and women's health markers. Public health collaborations emerging — HPV testing programs in Malaysia and Vietnam welcomed GBC's self-collection workflow. Demand for integrated assay ecosystems — hospitals prefer suppliers delivering systems + reagents under one brand. Localized clinical validation critical — ASEAN markets seek case studies aligned with MOH guidelines for rapid deployment.
EUROMEDLAB 2025
When
2025/05/18 – 05/22
Where
Brussels Expo
Booth
288
The 26th IFCC-EFLM European Congress of Clinical Chemistry and Laboratory Medicine (EUROMEDLAB 2025), combined with the 49th Annual Congress of the Royal Belgian Society of Laboratory Medicine, will take place from May 18 to 22, 2025, in Brussels, Belgium. The conference is jointly organized by the International Federation of Clinical Chemistry and Laboratory Medicine (IFCC), the European Federation of Clinical Chemistry and Laboratory Medicine (EFLM), and the Royal Belgian Society of Laboratory Medicine. The IFCC-EFLM EUROMEDLAB Congress will provide an excellent opportunity for attendees to engage with peers from around the world and discuss important issues related to current laboratory medicine science and technology.
AAMLS 2025
When
2025/04/10 – 04/13
Where
7th Floor, Hall 2,, Taipei Nangang Exhibition Center (TaiNEX 2)
Booth
B03-04
The AAMLS conference will be held from April 10 to 13, 2025, at TaiNEX 2, Taipei, Taiwan. This event is jointly organized with the 16th Asia-Pacific International Conference on Medical Laboratory Science by the Taiwan Association of Medical Technologists (TAMT) and is expected to attract approximately 2,000 domestic and 500 international participants. Precision, Innovation, and Legacy in Laboratory Medicine 2025 AAMLS Date: April 10–13, 2025Venue: TaiNEX 2, Taipei, TaiwanBooth: B03-04 We look forward to seeing you at the exhibition!
Medlab Middle East 2025
When
2025/02/03 – 02/06
Where
Dubai World Trade Centre
Booth
Z2.K59
MEDLAB Middle East 2025 The MEDLAB Middle East is the largest laboratory equipment exhibition in the Middle East. It showcases the latest products and cutting-edge technologies, establishing itself as the benchmark for the global laboratory equipment and diagnostics industry. Exhibition Dates: February 3–6, 2025Exhibition Hours: 09:00 AM–06:00 PMVenue: Dubai World Trade Centre
2024 Healthcare Expo Taiwan
When
2024/12/05 – 12/08
Where
Hall 1, Taipei Nangang Exhibition Center (TaiNEX 1)
Booth
L510
2024 Taiwan Healthcare+ Expo Successfully Concluded! This year's expo was a great success, with many distinguished guests visiting our booth. Accompanied by Minister of Health and Welfare Dr. Chiu Tai-Yuan, we were honored to welcome Dr. Ashok Philip, President of the World Medical Association, Dr. Jung Yul Park, Chair of the WMA Council, and Dr. Otmar Kloiber, Secretary-General of the WMA. Together, they explored GBC's latest innovations and breakthroughs in medical technology. One of the highlights at our booth was the GBC CL i120 chemiluminescence immunoassay (CLIA) analyzer, which officially received Taiwan TFDA special manufacturing approval in Q4. At the same time, we are actively progressing with the EU IVDR certification process, further supporting the growth of precision medicine. A heartfelt thank you to everyone who visited and supported us! Your encouragement inspires us to keep innovating and delivering even more breakthroughs in the future!
AMP 2024
When
2024/11/19 – 11/23
Where
Vancouver Convention Centre<br />(1055 Canada Pl Vancouver, BC V6C 0C3 Canada)
Booth
1330
AMP's Annual Meeting & Expo is the foremost gathering of molecular diagnostics professionals where all cutting-edge advancements in molecular diagnostics and medicine are explored. We are thrilled to invite you to the 30th Anniversary of the AMP 2024 Annual Meeting & Expo, where innovation meets collaboration in the field of molecular diagnostics. Event Details: Date: November 19-23, 2024Location: Vancouver Convention Centre, Vancouver, CanadaBooth: 1330 Visit our booth to explore our latest technologies and engage with our experts from General Biologicals Corporation (GBC). We are excited to showcase our innovative solutions designed to advance your laboratory's capabilities and drive better patient outcomes. Let's connect and explore the future of molecular diagnostics together. We look forward to seeing you at the venue!
TSLM Annual Meeting and Academic Conference 2024
When
2024/11/16 – 11/17
Where
NTUH international convention center
Booth
F41-43
The Annual Meeting and Academic Conference of the Taiwan Society of Laboratory Technologists will bring together experts and scholars in the field of medical laboratory science. They will explore the latest research findings and technological advancements and delve into cutting-edge knowledge in clinical diagnostics, molecular diagnostics, biomarker discovery, and more. We warmly invite you to attend the 113th Annual Member Conference and Academic Seminar of the Taiwan Society of Laboratory Medicine. This prestigious event will take place from November 16th to 17th, 2024, at the NTUH International Convention Center. It is a wonderful opportunity to explore the latest advancements in medical laboratory science, share professional knowledge, and strengthen industry connections. We look forward to seeing you there and welcome you to visit us at Booth F41-43. Let’s make this academic event a remarkable experience together!
FMA 2024 Medical Exhibition
When
2024/11/09 – 11/10
Where
NTUH international convention center
Booth
308-309
The FMA 2024 event brought together professionals and leading scholars from various fields to share the latest medical research and practical experiences. GBC showcased its Chemiluminescence Immunoassay (CLIA) technology, which is widely applied in tumor markers, thyroid function, infectious diseases, hormones, cytokines, cardiovascular, and other diagnostic areas. With high efficiency and precision (120-200 tests per hour), it meets the clinical laboratories' demand for efficient solutions. Additionally, the GBC AIO M160 Fully Automated Nucleic Acid Detection System is an integrated molecular diagnostics platform that combines DNA/RNA extraction, amplification, and data analysis functions. It features rapid and accurate detection (16 samples in 1-2 hours), safety (preventing cross-contamination), and convenience (fully automated workflow), effectively addressing modern diagnostic needs. The exhibition was a resounding success! We look forward to collaborating with more professionals in future medical society events to drive advancements in the medical field. Stay tuned to our official platforms for the latest updates!
2024 BIO Asia-Taiwan
When
2024/07/25 – 07/28
Where
Taipei Nangang Exhibition Center, Hall 1, 4F
Booth
M636
This year's BIO Asia-Taiwan 2024 was held at the Taipei Nangang Exhibition Center, Halls 1 and 2. This event will bring together bioindustry executives and investors from North America, Europe, and Asia to explore business opportunities and engage with Taiwan's emerging biotech sector. This year's theme, "Global View, Asian Touch," showcases the opportunities within Asia's fast-growing economies, its dynamic and innovative biomedical ecosystems, and its globally connected bioindustry production and value chains. At this exhibition, GBC is showcasing the CellBio™ circulating tumor cell detection product, a2000 CTC system, will be showcased. Visitors can also learn more about GBC's latest high-sensitivity and accuracy IVD technology, including the CLIA (chemiluminescent immunoassay) instruments and reagents, as well as the fully automated genetic nucleic acid detection and analysis system AIO M160, which flexibly integrates DNA/RNA nucleic acid extraction, amplification, and data analysis. Keep an eye on GBC's upcoming events and medical exhibitions. Welcome to explore more innovative technologies, products, and services.
The 98th Annual Meeting of the Japanese Association for Infectious Diseases
When
2024/06/27 – 06/29
Where
Kobe International Conference Center – Exhibition Hall 1
The Academic Conference of the Japan Society for Infectious Diseases is an important annual academic event in Japan aimed at promoting academic exchange and research progress in the field of infectious diseases. The conference brings together experts, scholars, and medical professionals from Japan and around the world to discuss the latest developments, research findings, and clinical practices related to infectious diseases. The conference covers various aspects of infectious diseases, including epidemic surveillance and control, pathogen identification and detection techniques, prevention and treatment of infectious diseases, vaccine development, and antibiotic resistance. Additionally, the conference provides opportunities for attendees to engage in academic exchange and collaboration, allowing researchers to exchange ideas and share experiences with industry representatives. The Academic Conference of the Japan Society for Infectious Diseases is considered an important platform for medical exchange, facilitating academic exchange, collaboration, and development in the field of infectious diseases. At this exhibition, GBC is showcasing the CellBio™ circulating tumor cell detection product, a2000 CTC system, will be showcased. Visitors can also learn more about GBC's latest high-sensitivity and accuracy IVD technology, including the CLIA (chemiluminescent immunoassay) instruments and reagents, as well as the fully automated genetic nucleic acid detection and analysis system AIO M160, which flexibly integrates DNA/RNA nucleic acid extraction, amplification, and data analysis. Keep an eye on GBC's upcoming events and medical exhibitions. Welcome to explore more innovative technologies, products, and services.
The 15th Asia-Pacific Forum of Medical Laboratory Science 2024
When
2024/04/20 – 04/21
Where
Kaohsiung Exhibition Center 3F
Booth
A8
The Asia-Pacific Medical Laboratory Science International Symposium provides a platform for academic exchange in medical laboratory sciences among countries in the Asia-Pacific region, enhancing the professionalism of medical laboratory personnel in Taiwan and aligning with international standards. This symposium fosters forward-thinking perspectives for the future development of medical laboratory practices in Taiwan on the international stage. Scheduled for April 20th to 21st, 2024, the symposium adopts the theme "Embracing the New Era of Precision Medicine Clinical Applications – M.T.s are ready" and invites participation from medical laboratory associations across Asia. At booth A8, GBC will showcase cutting-edge testing technologies including Chemiluminescence Immunoassay (CLIA) instruments and reagents known for their high sensitivity and accuracy, next-generation CellBio™ Circulating Tumor Cell (CTC) detection technology, as well as projects and services from CurieMed Corp. Through this exhibition at the international symposium, trends and new technologies in medical laboratory services are presented, elevating the standard of laboratory healthcare and showcasing the significance and position of Taiwan's medical laboratory practices on the global stage. We look forward to meeting you at the exhibition.
2024 Medlab Middle East
When
2024/02/05 – 02/08
Where
Dubai World Trade Centre
Booth
Z2.K59
GBC recently participated in the Medlab Middle East, an exhibition for laboratory equipment and devices held in Dubai, showcasing its expertise and technology in the field of precision medicine. Additionally, we unveiled the latest range of chemiluminescence products, as well as the CellBio™ Circulating Tumor Cell (CTC) detection system and the AIO fully automated nucleic acid detection device. Medlab Middle East, formerly part of the Arab Health exhibition, has operated independently since 2017 and has gradually become the world's largest exhibition for laboratory equipment and devices. At the exhibition, the GBC CL i120 fully automated chemiluminescence immunoassay system was showcased. This solution boasts features such as high efficiency, intelligence, convenience, flexibility, and reliability. With a maximum testing capacity of 120 tests per hour and the ability to accommodate 30 samples and testing items simultaneously, it provides clinical laboratories with high-throughput testing capabilities, thereby enhancing patient testing speed and efficiency. Another highlight for GBC was the development of the next generation GBC CellBio™ Circulating Tumor Cell (CTC) detection system. This system utilizes exclusive patented technology called iFiltration™, which can extract circulating tumor cells from small blood samples with a capture rate of over 90%. This technology aids doctors in timely detection and tracking of cancer cells within patients through non-invasive sampling processes, thereby providing earlier and more accurate treatment options for cancer patients. Furthermore, the AIO fully automated nucleic acid detection device was another focal point at the GBC booth. This device is capable of completing nucleic acid extraction to PCR analysis all on the same machine, with the ability to rapidly and accurately perform nucleic acid sequence detection analysis, which is significant for medical laboratories. Additionally, its enclosed design effectively mitigates the risk of cross-contamination, providing healthcare institutions with higher security assurance. During the exhibition in Dubai, GBC engaged in in-depth discussions and collaborations with healthcare professionals from around the world. This not only helps enhance the company's visibility and reputation in the international market but also contributes to further expanding its global presence. GBC remains committed to providing high-quality products and services, continuously driving the development and innovation of medical technology to achieve greater social value and contribution. For any inquiries or requirements regarding our products or services, please feel free to contact our customer service team.
2023 Healthcare Expo Taiwan
When
2023/11/30 – 12/03
Where
Hall 1, Taipei Nangang Exhibition Center
Booth
L130
The 2023 Healthcare⁺ EXPO is scheduled to take place from November 30th to December 3rd, with a particular focus on AI healthcare and opportunities in the field of large-scale health applications. GBC Precision Medicine, a prominent leader in the industry, will have their booth located in the Precision Medicine Zone on the 4th floor, booth number: L130. They will be showcasing their latest equipment, the CellBio™ Circulating Tumor Cell (CTC) cancer detection product, along with an array of medical monitoring services and technologies. These offerings represent highly competitive professional in vitro diagnostic (IVD) devices and reagents. Dates: 30 Nov -3 Dec, 2023Venue: Taipei Nangang Exhibition Center, Hall 1 (No. 1, Jingmao 2nd Rd., Nangang District, Taipei City, Taiwan)Exhibition Area: 4th Floor, Precision Medicine ZoneBooth: L130 This exhibition features three major themes: Smart Healthcare, Precision Medicine, and Lifelong Health. With a total of 2,500 exhibition booths, the event has seen remarkable growth, with participation from a diverse range of sectors, including hospitals, technology companies, and the biotechnology industry, all showing an increase of over 120%. Notably, it's not just the major medical centers but also more than 70 regional and specialized hospitals that are taking part. This exhibition showcases Taiwan's cutting-edge medical technology, clinical applications, and innovative validations, providing opportunities for both domestic and international businesses to collaborate and engage with potential procurement partners. GBC’s purpose has remained the same — to create better and more affordable in-vitro diagnostics that are accessible to everyone. Our in-vitro diagnostic tests portfolio including respiratory infections, blood virology, women’s and sexual health, oncology and human genetics and emerging infectious diseases, and equipment are now the trusted solution for hospital professionals, lab technicians, blood banks, and consumers worldwide. GB CellBio™, utilizes an exclusive patented membrane separation method known as iFiltration™. It allows for the rapid and efficient capture of circulating tumor cells (CTCs) in human blood using a physical approach that preserves cell morphology and retains target antigens and other specific markers. For individuals undergoing the testing service, all that is required is to make an online appointment and provide a non-fasting blood sample of 7.5 c.c, a process that takes only 10-15 minutes. Reports are then sent out within 7 business days. This facilitates the assessment of treatment effectiveness, the precise formulation of personalized treatment plans, and the continuous monitoring of changes in CTC count, ensuring the effective understanding of treatment timing and outcomes. During the exhibition, we are extremely grateful for the attention and feedback on our products from all sectors. These suggestions have a profound impact on the research and improvement of our products, making them critically important to us. The support and feedback from our customers will help us continually enhance the quality of our products to meet their needs. We look forward to establishing a closer mutually beneficial relationship, exploring more collaborative opportunities, and providing more professional, high-quality services. Thank you to our partners for participating in the medical exhibition. If you have any needs or inquiries, please feel free to contact us. Link: Contact Us
2023 AACC Annual Scientific Meeting & Clinical Lab Expo
When
2023/07/23 – 07/27
Where
Anaheim Convention Center Anaheim, California
Booth
3688
GBC Unveils Innovative Patent Technology at AACC Annual Clinical Conference On July 23, 2023, the AACC Annual Scientific Meeting & Clinical Lab Expo, a prestigious event in the realm of clinical chemistry and clinical laboratory medicine, kicked off in the United States. GBC, known as a pioneer in medical innovation, showcased two cutting-edge in vitro diagnostic (IVD) devices and reagents for cancer testing at booth number 3688. These products, under the brand name CellBio™ Circulating Tumor Cell (CTC) cancer testing systems, are setting new standards in the field. Since its inception in 1949, AACC has grown into the largest and most esteemed annual gathering in the global clinical testing domain. Each year, the event provides a platform for the latest advancements in clinical laboratory testing technology and in vitro diagnostic products, drawing substantial international attention. The 2023 expo attracted participants from over 110 countries and regions, with more than 800 exhibitors and over 20,000 professionals in the field, all converging to showcase their groundbreaking innovations. GBC's two CTC testing systems have earned international recognition as pioneering solutions, designed for early cancer detection, treatment validation, and therapy monitoring. These systems offer swift, accessible, and cost-effective diagnostic answers. CellBio™ leverages GBC's patented iFiltration™ technology, an innovative combination of physical filtration methods and fluorescence staining. It excels in the separation and recovery of CTCs from human blood samples, distinguishing cells based on size and distinct surface markers. With an outstanding recovery rate exceeding 97%, it outperforms existing technologies in the market. Its high sensitivity and specificity empower researchers and clinical professionals to conduct reliable and precise analyses, offering a powerful tool for understanding tumor progression. Mr. Frank Lin , the President of GBC, expressed, "CellBio™ is dedicated to the detection, monitoring, and treatment of cancer metastasis. GBC's mission is to revolutionize cancer detection and treatment through our unique CTC technology and the complementary CellBio™ therapy platform." He further emphasized, "With over 10 million patients succumbing to cancer annually, and more than 90% of these fatalities attributed to metastasis, monitoring CTCs holds the potential to make a substantial impact on cancer metastasis and patient outcomes." GBC remains devoted to the development of advanced medical technologies and solutions aimed at enhancing the convenience and efficiency of medical services. Through a commitment to continuous innovation and optimization, GBC's solutions have been widely adopted globally. Looking ahead, GBC is dedicated to pushing the boundaries, offering innovative and practical solutions for the clinical laboratory and diagnostic medicine fields.
2023 Medlab Middle East
When
2023/02/06 – 02/09
Where
Dubai World Trade Centre
Booth
Z2/K53
On February 6, 2023, the Medlab Middle East opened in the Dubai World Trade Centre. This exhibition is renowned as one of the largest professional medical equipment exhibitions in the Middle East and is also an integral part of the global laboratory professional exhibitions. GBC, with booth number Z2/K53, unveiled its latest CellBio™ Circulating Tumor Cell (CTC) cancer detection product and the fully automatic genetic nucleic acid testing and analysis system AIO M160. These two systems offer highly competitive in vitro diagnostic (IVD) devices and reagents. Medlab Middle East is highly esteemed and recommended by the International Association of Scientific Equipment and Laboratory Furniture (SEFA) in the United States. It is recognized as a globally recommended exhibition. This exhibition brings together over 700 medical laboratory equipment manufacturers from more than 50 countries, attracting over 25,000 professional attendees for trade exchanges. Together, they explore cutting-edge diagnostic technologies and innovative laboratory medical solutions, providing a crucial platform for professionals in the medical field to exchange ideas and knowledge. This year, GBC is focusing on its GB CellBio™ system, which can capture and harvest circulating tumor cells and other abnormal cells for clinical and research applications. The key feature of this technology is its ability to perform repeated blood draws, continually enriching the sample and providing more comprehensive data for cancer research. Unlike traditional ctDNA techniques, CTC technology can offer a more comprehensive analysis and serves as a potential alternative to tissue biopsies. At the exhibition, GBC's products received widespread acclaim from industry professionals and attracted the interest of many potential clients seeking collaboration. With over three decades of experience, GBC has developed a comprehensive supply chain covering research, development, manufacturing, sales, and testing services, all aimed at delivering improved and cost-effective in vitro diagnostic (IVD) products. Their product range spans infectious diseases, respiratory infections, hematology, reproductive health, oncology, human genetics, and emerging infectious diseases, among others. GBC's products and equipment are trusted solutions for healthcare professionals, lab technicians, blood banks, and consumers, distributed in over 40 countries worldwide. GBC, starting from diagnostics, is committed to integrating testing with various therapeutic approaches, working towards precision, prevention, and the broader field of holistic well-being. The company has diversified its business into several areas, including precision in vitro diagnostic reagents (IVD), digital medical diagnostic services (DML), antimicrobial peptide (AMP) drugs, and health products, contributing to the long-term development of the holistic well-being sector.
2022 Healthcare Expo Taiwan
When
2022/12/01 – 12/04
Where
Hall 1, Taipei Nangang Exhibition Center
Booth
N1024
Taipei Maternal & Child Product Expo
When
2022/10/07 – 10/10
Where
Hall 2, TaiNEX 2 Exhibition Center, Taipei
Booth
D211
2022 BIO Asia–Taiwan
When
2022/07/28 – 07/31
Where
Hall 2, TaiNEX 2 Exhibition Center, Taipei
Booth
S610
Awards & Recognition
GBC has been consistently recognized by the industry for its breakthroughs in diagnostics, precision medicine, and healthcare innovation, reflecting our commitment to advancing global health.
Classification
| Title | Awarded by | Year | |
|---|---|---|---|
|
2025 US Edison Awards
|
Edison Awards | 2025 | |
|
2025 Taiwan Excellence Award
|
International Trade Administration | 2025 | |
|
2025 IMDA Award
oh care Newborn Oral Care Set |
International Maternal and Infant Industry Development Association (IMDA) | 2025 | |
|
2024 SNQ Symbol of National Quality Certification
|
Institute for Biotechnology and Medicine Industry (IBMI) | 2024 | |
|
2023 National Innovation Award
CellBio™ CTC System |
National Biotechnology and Medical Industry Promotion Association | 2023 | |
|
26th National Biotechnology Medical Quality Award Bronze Award
SNQ National Quality Award oh care P113+ Children’s Mouthwash |
Institute for Biotechnology and Medicine Industry | 2023 | |
|
National Pharmaceutical Technology & Research Development Awards
GBC CellBio™ Technology Platform received the Bronze Award at the National Pharmaceutical Technology & Research Development Awards. |
TFDA / Ministry of Economic Affairs | 2023 | |
|
The 31st Taiwan Excellence Award – P113+ Antibacterial Peptide Fluoride Toothpaste for Kids [Grape]
The 31st Taiwan Excellence Award-P113+ Antibacterial Peptide Fluoride Toothpaste for Kids [Grape] |
Ministry of Economic Affairs | 2023 | |
|
2022 Asia Pacific Enterprise Awards
https://apea.asia/hall-of-fame-tw-2022/ |
Enterprise Asia | 2022 | |
|
2022 HR Asia Best Companies to Work for in Asia
2022 HR Asia Best Companies to Work for in Asia |
HR Asia | 2022 | |
|
The 19th National Innovation Award – Enterprise Innovation Award
The 19th National Innovation Award – Enterprise Innovation Award “Blood Circulating Tumor Cell Detection System (CellBioTM)” https://innoaward.taiwan-healthcare.org/ |
National Biotechnology and Medical Industry Promotion Association | 2022 | |
|
2021 Top 100 MVP Managers – Product Innovation Award
Product Innovation Award |
Manager magazine | 2021 | |
|
2020 Pharmaceutical Technology & Research Development Award
GB SARS-CoV-2 Real-Time RT-PCR |
TFDA / Ministry of Economic Affairs | 2020 | |
|
2020 SNQ National Biotech Industrial Award
BioFibroScore® Non-invasive liver fibrosis detection platform was awarded Bronze Award in SNQ National Biotechnology and Medical Quality by Department of Economics Development Taiwan. |
Department of Economics Development Taiwan | 2020 | |
|
2020 SNQ National Quality Award
Oh care P113+ Anti-Bacterial Kids Mouth Spray was awarded 2020 SNQ National Quality Award |
Institute for Biotechnology and Medicine Industry Taiwan | 2020 | |
|
2019 SNQ National Biotech Industrial Award
BioFibroScore® Non-invasive liver fibrosis detection platform was awarded Bronze Award in SNQ National Biotechnology and Medical Quality by Department of Economics Development Taiwan. |
Department of Economics Development Taiwan | 2019 | |
|
2019 SNQ National Quality Award
oh care P113+ Anti-Bacterial Kids Mouth Spray was awarded 2019 SNQ National Quality Award |
Institute for Biotechnology and Medicine Industry Taiwan | 2019 | |
|
2018 SNQ National Quality Award
oh care P113+ kids mouth spray |
Institute for Biotechnology and Medicine Industry Taiwan | 2018 | |
|
2018 SNQ National Quality Award
BioFibroScore® was awarded 2015 SNQ National Quality Award |
Institute for Biotechnology and Medicine Industry Taiwan | 2018 | |
|
The 15th Annual Taiwan Golden Root Awards
|
Taiwan Industrial Technology Association (TITA) | 2018 | |
|
2017 SNQ National Biotech Industrial Award
BioFibroScore® Non-invasive liver fibrosis detection platform was awarded Bronze Award in SNQ National Biotechnology and Medical Quality by Department of Economics Development Taiwan. |
Department of Economics Development Taiwan | 2017 | |
|
2017 SNQ National Quality Award
oh care P113+ Anti-Bacterial Kids Mouth Spray was awarded 2015 SNQ National Quality Award |
Institute for Biotechnology and Medicine Industry Taiwan | 2017 | |
|
2017 iF Design Award
oh care was awarded 2017 iF Design Award – Branding |
iF International Forum Design GmbH | 2017 | |
|
2016 SNQ National Biotech Industrial Award
BioFibroScore® Non-invasive liver fibrosis detection platform was awarded Bronze Award in SNQ National Biotechnology and Medical Quality by Department of Economics Development Taiwan. |
Department of Economics Development Taiwan | 2016 | |
|
2016 SNQ National Quality Award
oh care P113+ Anti-Bacterial Kids Mouth Spray was awarded 2015 SNQ National Quality Award |
Institute for Biotechnology and Medicine Industry Taiwan | 2016 | |
|
2015 SNQ National Quality Award
oh care P113+ Anti-Bacterial Kids Mouth Spray was awarded 2015 SNQ National Quality Award |
Institute for Biotechnology and Medicine Industry Taiwan | 2015 | |
|
2015 Asia Pacific Entrepreneuship Awards
Chairman T.C. Lin was awarded one of the 7 Most Promising Entrepreneurship Award. |
Asia Pacific Entrepreneurship Awards (APEA) | 2015 | |
|
2015 Troponin-I POCT Excellence Award
GBC’s newest POCT (Point of Care Testing) system was awarded an Excellence Award by Ministry of Science and Technology Taiwan |
Ministry of Science and Technology Taiwan | 2015 | |
|
2015 SNQ National Quality Award
BioFibroScore® was awarded 2015 SNQ National Quality Award – 3rd Place. |
Institute for Biotechnology and Medicine Industry Taiwan | 2015 | |
|
2014 Taipei Biotechnology Award
BioFibroScore® – a non-invasive liver fibrosis platform was awarded Gold Award in Taipei Biotechnology Award by Department of Economics Development Taiwan |
Department of Economics Development Taiwan | 2014 | |
|
The 2nd Taiwan Mittelstand Award
GBC was awarded for the 2nd Taiwan Mittelstand and Counseling Targets from Industrial Development Bureau,Ministry of Economic Affairs. |
Industrial Development Bureau Ministry of Economic Affairs | 2014 | |
|
The 10th National Innovation Award
GBC was awarded by The Institute for Biotechnology and Medicine Industry (IBMI) “The 10th National Innovation Award”. |
The Institute for Biotechnology and Medicine Industry (IBMI) | 2013 | |
|
2013 Honor Award of Golden Torch Award Selection
GBC was awarded by Honor Award of Golden Torch Award Selection. The award celebration was hosted by Chinese Outstanding Enterprise Manager Association |
Chinese Outstanding Enterprise Manager Association | 2013 | |
|
2013 Taiwan BIO Award – Innovation of the Year
GBC was awarded by Bio Taiwan Industry Organization “2013 Taiwan BIO Award – Innovation of the Year”. |
Bio Taiwan Industry Organization | 2013 | |
|
2012 Industrial Innovation Recognition Award
The award was established by Economic Department Technology Department in Taiwan to encourage new innovation from small to large companies. GBC was awarded as one of “Best Innovations in Technology in 2012” categories. |
Ministry of Economic Affairs Taiwan | 2012 | |
|
The 9th Annual Taiwan Golden Root Awards
The Annual Taiwan Golden Root Awards are giving out to the most prominent with the highest potential in Taiwan by TITA (Taiwan Industrial Technology Association). Only a limited of companies were selected each year. GBC was awarded in 2011. |
Taiwan Industrial Technology Association (TITA) | 2011 | |
|
2010 D&B and Standard Chartered Award
GBC was awarded as one of top 100 the most respectful high tech company in Taiwan by Standard Chartered. |
Standard Chartered | 2010 | |
|
The 8th Annual the Most Innovative Product Design Award
GBC was awarded by Taiwan Government (small-medium business division) one of the most innovative companies in year 2001. |
Ministry of Economic Affairs Taiwan | 2001 | |
|
The National Biotech Industrial Award
The award was considered to be equivalent to “Oscar Award” and was the most prestige award in Life Science / Biotech industry in Taiwan. We at GBC were selected as one of top 4 companies in year 2000. |
he Institute for Biotechnology and Medicine Industry (IBMI) | 2000 |
2025 US Edison Awards
Awarded by
Edison Awards
Edison Awards
Year
2025
2025
2025 Taiwan Excellence Award
Awarded by
International Trade Administration
International Trade Administration
Year
2025
2025
2025 IMDA Award
oh care Newborn Oral Care Set
Winner of the 2025 Golden Baby Awards – Outstanding Maternal & Infant Product
Awarded by
International Maternal and Infant Industry Development Association (IMDA)
International Maternal and Infant Industry Development Association (IMDA)
Year
2025
2025
2024 SNQ Symbol of National Quality Certification
Awarded by
Institute for Biotechnology and Medicine Industry (IBMI)
Institute for Biotechnology and Medicine Industry (IBMI)
Year
2024
2024
2023 National Innovation Award
CellBio™ CTC System
Awarded by
National Biotechnology and Medical Industry Promotion Association
National Biotechnology and Medical Industry Promotion Association
Year
2023
2023
26th National Biotechnology Medical Quality Award Bronze Award
SNQ National Quality Award
oh care P113+ Children’s Mouthwash
Awarded by
Institute for Biotechnology and Medicine Industry
Institute for Biotechnology and Medicine Industry
Year
2023
2023
National Pharmaceutical Technology & Research Development Awards
GBC CellBio™ Technology Platform received the Bronze Award at the National Pharmaceutical Technology & Research Development Awards.
Awarded by
TFDA / Ministry of Economic Affairs
TFDA / Ministry of Economic Affairs
Year
2023
2023
The 31st Taiwan Excellence Award – P113+ Antibacterial Peptide Fluoride Toothpaste for Kids [Grape]
The 31st Taiwan Excellence Award-P113+ Antibacterial Peptide Fluoride Toothpaste for Kids [Grape]
Awarded by
Ministry of Economic Affairs
Ministry of Economic Affairs
Year
2023
2023
2022 Asia Pacific Enterprise Awards
https://apea.asia/hall-of-fame-tw-2022/
Awarded by
Enterprise Asia
Enterprise Asia
Year
2022
2022
2022 HR Asia Best Companies to Work for in Asia
2022 HR Asia Best Companies to Work for in Asia
Awarded by
HR Asia
HR Asia
Year
2022
2022
The 19th National Innovation Award – Enterprise Innovation Award
The 19th National Innovation Award – Enterprise Innovation Award
“Blood Circulating Tumor Cell Detection System (CellBioTM)”
https://innoaward.taiwan-healthcare.org/
Awarded by
National Biotechnology and Medical Industry Promotion Association
National Biotechnology and Medical Industry Promotion Association
Year
2022
2022
2021 Top 100 MVP Managers – Product Innovation Award
Product Innovation Award
Awarded by
Manager magazine
Manager magazine
Year
2021
2021
2020 Pharmaceutical Technology & Research Development Award
GB SARS-CoV-2 Real-Time RT-PCR
Awarded by
TFDA / Ministry of Economic Affairs
TFDA / Ministry of Economic Affairs
Year
2020
2020
2020 SNQ National Biotech Industrial Award
BioFibroScore® Non-invasive liver fibrosis detection platform was awarded Bronze Award in SNQ National Biotechnology and Medical Quality by Department of Economics Development Taiwan.
Awarded by
Department of Economics Development Taiwan
Department of Economics Development Taiwan
Year
2020
2020
2020 SNQ National Quality Award
Oh care P113+ Anti-Bacterial Kids Mouth Spray was awarded 2020 SNQ National Quality Award
Awarded by
Institute for Biotechnology and Medicine Industry Taiwan
Institute for Biotechnology and Medicine Industry Taiwan
Year
2020
2020
2019 SNQ National Biotech Industrial Award
BioFibroScore® Non-invasive liver fibrosis detection platform was awarded Bronze Award in SNQ National Biotechnology and Medical Quality by Department of Economics Development Taiwan.
Awarded by
Department of Economics Development Taiwan
Department of Economics Development Taiwan
Year
2019
2019
2019 SNQ National Quality Award
oh care P113+ Anti-Bacterial Kids Mouth Spray was awarded 2019 SNQ National Quality Award
Awarded by
Institute for Biotechnology and Medicine Industry Taiwan
Institute for Biotechnology and Medicine Industry Taiwan
Year
2019
2019
2018 SNQ National Quality Award
oh care P113+ kids mouth spray
Awarded by
Institute for Biotechnology and Medicine Industry Taiwan
Institute for Biotechnology and Medicine Industry Taiwan
Year
2018
2018
2018 SNQ National Quality Award
BioFibroScore® was awarded 2015 SNQ National Quality Award
Awarded by
Institute for Biotechnology and Medicine Industry Taiwan
Institute for Biotechnology and Medicine Industry Taiwan
Year
2018
2018
The 15th Annual Taiwan Golden Root Awards
Awarded by
Taiwan Industrial Technology Association (TITA)
Taiwan Industrial Technology Association (TITA)
Year
2018
2018
2017 SNQ National Biotech Industrial Award
BioFibroScore® Non-invasive liver fibrosis detection platform was awarded Bronze Award in SNQ National Biotechnology and Medical Quality by Department of Economics Development Taiwan.
Awarded by
Department of Economics Development Taiwan
Department of Economics Development Taiwan
Year
2017
2017
2017 SNQ National Quality Award
oh care P113+ Anti-Bacterial Kids Mouth Spray was awarded 2015 SNQ National Quality Award
Awarded by
Institute for Biotechnology and Medicine Industry Taiwan
Institute for Biotechnology and Medicine Industry Taiwan
Year
2017
2017
2017 iF Design Award
oh care was awarded 2017 iF Design Award – Branding
Awarded by
iF International Forum Design GmbH
iF International Forum Design GmbH
Year
2017
2017
2016 SNQ National Biotech Industrial Award
BioFibroScore® Non-invasive liver fibrosis detection platform was awarded Bronze Award in SNQ National Biotechnology and Medical Quality by Department of Economics Development Taiwan.
Awarded by
Department of Economics Development Taiwan
Department of Economics Development Taiwan
Year
2016
2016
2016 SNQ National Quality Award
oh care P113+ Anti-Bacterial Kids Mouth Spray was awarded 2015 SNQ National Quality Award
Awarded by
Institute for Biotechnology and Medicine Industry Taiwan
Institute for Biotechnology and Medicine Industry Taiwan
Year
2016
2016
2015 SNQ National Quality Award
oh care P113+ Anti-Bacterial Kids Mouth Spray was awarded 2015 SNQ National Quality Award
Awarded by
Institute for Biotechnology and Medicine Industry Taiwan
Institute for Biotechnology and Medicine Industry Taiwan
Year
2015
2015
2015 Asia Pacific Entrepreneuship Awards
Chairman T.C. Lin was awarded one of the 7 Most Promising Entrepreneurship Award.
Awarded by
Asia Pacific Entrepreneurship Awards (APEA)
Asia Pacific Entrepreneurship Awards (APEA)
Year
2015
2015
2015 Troponin-I POCT Excellence Award
GBC’s newest POCT (Point of Care Testing) system was awarded an Excellence Award by Ministry of Science and Technology Taiwan
Awarded by
Ministry of Science and Technology Taiwan
Ministry of Science and Technology Taiwan
Year
2015
2015
2015 SNQ National Quality Award
BioFibroScore® was awarded 2015 SNQ National Quality Award – 3rd Place.
Awarded by
Institute for Biotechnology and Medicine Industry Taiwan
Institute for Biotechnology and Medicine Industry Taiwan
Year
2015
2015
2014 Taipei Biotechnology Award
BioFibroScore® – a non-invasive liver fibrosis platform was awarded Gold Award in Taipei Biotechnology Award by Department of Economics Development Taiwan
Awarded by
Department of Economics Development Taiwan
Department of Economics Development Taiwan
Year
2014
2014
The 2nd Taiwan Mittelstand Award
GBC was awarded for the 2nd Taiwan Mittelstand and Counseling Targets from Industrial Development Bureau,Ministry of Economic Affairs.
Awarded by
Industrial Development Bureau Ministry of Economic Affairs
Industrial Development Bureau Ministry of Economic Affairs
Year
2014
2014
The 10th National Innovation Award
GBC was awarded by The Institute for Biotechnology and Medicine Industry (IBMI) “The 10th National Innovation Award”.
Awarded by
The Institute for Biotechnology and Medicine Industry (IBMI)
The Institute for Biotechnology and Medicine Industry (IBMI)
Year
2013
2013
2013 Honor Award of Golden Torch Award Selection
GBC was awarded by Honor Award of Golden Torch Award Selection. The award celebration was hosted by Chinese Outstanding Enterprise Manager Association
Awarded by
Chinese Outstanding Enterprise Manager Association
Chinese Outstanding Enterprise Manager Association
Year
2013
2013
2013 Taiwan BIO Award – Innovation of the Year
GBC was awarded by Bio Taiwan Industry Organization “2013 Taiwan BIO Award – Innovation of the Year”.
Awarded by
Bio Taiwan Industry Organization
Bio Taiwan Industry Organization
Year
2013
2013
2012 Industrial Innovation Recognition Award
The award was established by Economic Department Technology Department in Taiwan to encourage new innovation from small to large companies. GBC was awarded as one of “Best Innovations in Technology in 2012” categories.
Awarded by
Ministry of Economic Affairs Taiwan
Ministry of Economic Affairs Taiwan
Year
2012
2012
The 9th Annual Taiwan Golden Root Awards
The Annual Taiwan Golden Root Awards are giving out to the most prominent with the highest potential in Taiwan by TITA (Taiwan Industrial Technology Association). Only a limited of companies were selected each year. GBC was awarded in 2011.
Awarded by
Taiwan Industrial Technology Association (TITA)
Taiwan Industrial Technology Association (TITA)
Year
2011
2011
2010 D&B and Standard Chartered Award
GBC was awarded as one of top 100 the most respectful high tech company in Taiwan by Standard Chartered.
Awarded by
Standard Chartered
Standard Chartered
Year
2010
2010
The 8th Annual the Most Innovative Product Design Award
GBC was awarded by Taiwan Government (small-medium business division) one of the most innovative companies in year 2001.
Awarded by
Ministry of Economic Affairs Taiwan
Ministry of Economic Affairs Taiwan
Year
2001
2001
The National Biotech Industrial Award
The award was considered to be equivalent to “Oscar Award” and was the most prestige award in Life Science / Biotech industry in Taiwan. We at GBC were selected as one of top 4 companies in year 2000.
Awarded by
he Institute for Biotechnology and Medicine Industry (IBMI)
he Institute for Biotechnology and Medicine Industry (IBMI)
Year
2000
2000
No awards are available.
Marketing Downloads
Brand assets available: logos in PNG/JPG/PDF formats, product images, video files—ready for media use and brand promotion.
